Market Research Logo

Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2018

Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2018 provides an overview of Cardiac Resynchronisation Therapy (CRT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Resynchronisation Therapy (CRT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Resynchronisation Therapy (CRT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy (CRT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Resynchronisation Therapy (CRT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


  • Introduction
    • Cardiac Resynchronisation Therapy (CRT) Overview
  • Products under Development
    • Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
      • Table Figure 1: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
      • Table Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
    • Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
      • Table Figure 2: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment Pipeline Products by Segment n=19
      • Table Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
    • Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
      • Table Figure 3: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
      • Table Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
    • Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
      • Table Figure 4: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
      • Table Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
    • Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
      • Table Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
    • Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
      • Table Figure 6: Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
      • Table Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
  • Cardiac Resynchronisation Therapy (CRT) - Pipeline Products under Development by Companies
    • Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development
      • Table Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development
    • Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
      • Table Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of under Development
  • Cardiac Resynchronisation Therapy (CRT) Companies and Product Overview
    • AI Medical Semiconductor Ltd. Company Overview
      • AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adaptive CRT And Vagal Stimulation Device - Product Status
        • Table Adaptive CRT And Vagal Stimulation Device - Product Description
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Quad Polar CRT-D - Product Status
        • Table Next Generation Quad Polar CRT-D - Product Description
        • Table NG3 Non Quad System - Product Status
        • Table NG3 Non Quad System - Product Description
        • Table Boston Scientific Corp - Ongoing Clinical Trials Overview
        • Table Next Generation Quad Polar CRT-D - Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
    • DHS Medical Company Overview
      • DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drimmer - Product Status
        • Table Drimmer - Product Description
        • Table Twistek - Product Status
        • Table Twistek - Product Description
    • EBR Systems Inc Company Overview
      • EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Second Generation WiSE CRT System - Product Status
        • Table Second Generation WiSE CRT System - Product Description
        • Table WiSE CRT System - Product Status
        • Table WiSE CRT System - Product Description
        • Table EBR Systems Inc - Ongoing Clinical Trials Overview
        • Table WiSE CRT System - Multicenter, Prospective Evaluation of Safety and Performance of the WiCSLV System in Patients Indicated for Cardiac Resynchronization Therapy
        • Table WiSE CRT System - Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders and Previously Untreatable Patients: SOLVE CRT
        • Table WiSE CRT System - WiCS-LV Post Market Surveillance Registry
    • IRadimed Corp Company Overview
      • IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MRI Defibrillator - Product Status
        • Table MRI Defibrillator - Product Description
    • Johns Hopkins University Company Overview
      • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiac Arrhythmia Termination Device - Product Status
        • Table Cardiac Arrhythmia Termination Device - Product Description
    • LivaNova PLC Company Overview
      • LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Status
        • Table Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Description
    • Mayo Clinic Company Overview
      • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Atrial Fibrillation Device - Product Status
        • Table Atrial Fibrillation Device - Product Description
    • Medtronic plc Company Overview
      • Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Status
        • Table Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Description
        • Table Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Status
        • Table Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Description
        • Table MRI Safe CRT-D - Product Status
        • Table MRI Safe CRT-D - Product Description
        • Table Medtronic plc - Ongoing Clinical Trials Overview
        • Table Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Optimizing Pacemaker Therapy Using Multi-point Pacing: The OPT-MPP Study
        • Table Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Personalized CRT - Multiple Point Pacing Post Approval Study
        • Table Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Optimizing Pacemaker Therapy Using Multi-point Pacing: The OPT-MPP Study
        • Table Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Personalized CRT - Multiple Point Pacing Post Approval Study
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table PARADYM RF SonR CRT-D - Product Status
        • Table PARADYM RF SonR CRT-D - Product Description
    • NewPace Ltd Company Overview
      • NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Implantable Subcutaneous String Defibrillator (ISSD) - Product Status
        • Table The Implantable Subcutaneous String Defibrillator (ISSD) - Product Description
        • Table NewPace Ltd - Ongoing Clinical Trials Overview
        • Table The Implantable Subcutaneous String Defibrillator (ISSD) - Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment
    • Odem Medical Ltd Company Overview
      • Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Odem Device - Product Status
        • Table Odem Device - Product Description
    • St. Jude Medical LLC Company Overview
      • St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quadra Allure MP CRT-P - MRI Labeling - Product Status
        • Table Quadra Allure MP CRT-P - MRI Labeling - Product Description
    • TransWorld Med Corp Company Overview
      • TransWorld Med Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table TransWorld Med Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soul Mate - Pacemaker - Product Status
        • Table Soul Mate - Pacemaker - Product Description
  • Cardiac Resynchronisation Therapy (CRT)- Recent Developments
    • May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
    • Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
    • Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
    • Apr 03, 2018: Nihon Kohden Announces Change in Representative Director and Director
    • Mar 10, 2018: LifeVest Wearable Defibrillator Reduces Total Mortality By 36 Percent At 90 Days
    • Mar 07, 2018: EBR Systems Initiates Global Trial of World's Only Wireless CRT Pacing Technology
    • Mar 01, 2018: Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker
    • Mar 01, 2018: First BIOTRONIK Pacemakers in Japan Approved for 3 Tesla Full-Body MRIs
    • Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results
    • Feb 27, 2018: genedrive Receives Significant Funding for TB Test Development
    • Feb 26, 2018: Medtronic Recalls Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillators Due to Manufacturing Error Preventing Electrical Shock Delivery
    • Feb 26, 2018: Tissue Regenix Group: Launch of TRX BioSurgery and new distributor agreement
    • Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
    • Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
    • Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
    • Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
    • Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development
    • Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
    • Dec 19, 2017: Bluetooth Pacemakers Offer Convenience and Cost Savings
    • Dec 13, 2017: Electric eel inspires new power source
    • Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
    • Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
    • Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
    • Nov 02, 2017: Mexican doctors safely reuse donated pacemakers after sterilization
    • Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results
    • Nov 02, 2017: Nihon Kohden opens a sales branch in Kenya
    • Oct 31, 2017: AHA/ACC/HRS Publish New Guidelines on the Wearable Cardioverter Defibrillator for Patients at Risk of Sudden Cardiac Death
    • Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
    • Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
    • Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
    • Sep 27, 2017: ZOLL Canada Wins Tender to Equip Province of Quebec Paramedic Services with ZOLL X Series Monitor/Defibrillators
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Aug 21, 2017: BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
    • Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results
    • Aug 03, 2017: BIOTRONIK's Newest CRT-D Device with MultiPole Pacing Now Available in Japan
    • Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
    • Jul 19, 2017: Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology For Heart Failure Patients
    • Jul 13, 2017: Nihon Kohden Selected for FTSE4Good Index Series and FTSE Blossom Japan Index
    • Jul 10, 2017: BIOTRONIK's New Quadripolar CRT-P with More Pacing Options Now Available in Japan
    • Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
    • Jun 20, 2017: EBR Systems Awarded Favorite Innovation for WiSE CRT at 2017 EHRA Europace Cardiostim Congress
    • Jun 13, 2017: Nihon Kohden to reorganize its group companies in India
    • Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report